• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞移动抑制因子:癌症诊断与治疗的潜在标志物。

Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy.

作者信息

Babu Spoorthy N, Chetal Gaurav, Kumar Sudhir

机构信息

IGNOU-I2IT Centre of Excellence for Advanced Education and Research, Pune, Maharashtra, India.

出版信息

Asian Pac J Cancer Prev. 2012;13(5):1737-44. doi: 10.7314/apjcp.2012.13.5.1737.

DOI:10.7314/apjcp.2012.13.5.1737
PMID:22901113
Abstract

Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine which plays roles in inflammation, immune responses and cancer development. It assists macrophages in carrying out functions like phagocytosis, adherence and motility. Of late, MIF is implicated in almost all stages of neoplasia and expression is a feature of most types of cancer. The presence of MIF in almost all tumors and all stages of cancer makes it an interesting candidate for cancer therapy. This review explores the roles of MIF in neoplasia.

摘要

巨噬细胞移动抑制因子(MIF)是一种多能细胞因子,在炎症、免疫反应和癌症发展中发挥作用。它协助巨噬细胞执行吞噬、黏附和移动等功能。近来,MIF几乎涉及肿瘤形成的所有阶段,且其表达是大多数癌症类型的一个特征。MIF存在于几乎所有肿瘤及癌症的各个阶段,这使其成为癌症治疗中一个引人关注的候选对象。本综述探讨了MIF在肿瘤形成中的作用。

相似文献

1
Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy.巨噬细胞移动抑制因子:癌症诊断与治疗的潜在标志物。
Asian Pac J Cancer Prev. 2012;13(5):1737-44. doi: 10.7314/apjcp.2012.13.5.1737.
2
The Macrophage migration inhibitory factor is a vital player in Pan-Cancer by functioning as a M0 Macrophage biomarker.巨噬细胞移动抑制因子是癌症的一个重要标志物,通过作为 M0 巨噬细胞发挥作用。
Int Immunopharmacol. 2024 Jun 15;134:112198. doi: 10.1016/j.intimp.2024.112198. Epub 2024 May 10.
3
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.巨噬细胞移动抑制因子(MIF):生物学活性及其与癌症的关系。
Pathol Oncol Res. 2017 Apr;23(2):235-244. doi: 10.1007/s12253-016-0138-6. Epub 2016 Oct 23.
4
Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.巨噬细胞移动抑制因子作为胃癌潜在的预后因素
World J Gastroenterol. 2015 Sep 14;21(34):9916-26. doi: 10.3748/wjg.v21.i34.9916.
5
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.氧化型巨噬细胞移动抑制因子是癌症中一种潜在的新型组织标志物和药物靶点。
Oncotarget. 2016 Nov 8;7(45):73486-73496. doi: 10.18632/oncotarget.11970.
6
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.巨噬细胞移动抑制因子——胆囊癌的一个治疗靶点。
BMC Cancer. 2015 Nov 4;15:843. doi: 10.1186/s12885-015-1855-z.
7
Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).禽类巨噬细胞移动抑制因子(MIF)的分子克隆与功能鉴定。
Dev Comp Immunol. 2010 Sep;34(9):1021-32. doi: 10.1016/j.dci.2010.05.005. Epub 2010 May 20.
8
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.巨噬细胞移动抑制因子与宿主针对细菌性败血症的固有免疫防御
J Infect Dis. 2003 Jun 15;187 Suppl 2:S385-90. doi: 10.1086/374752.
9
Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.细胞表面的syndecan-1有助于巨噬细胞移动抑制因子(MIF)在上皮肿瘤细胞上的结合及发挥功能。
Biochim Biophys Acta. 2016 Apr;1863(4):717-26. doi: 10.1016/j.bbamcr.2016.02.003. Epub 2016 Feb 4.
10
Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).巨噬细胞移动抑制因子(MIF)通过调节Toll样受体4(TLR4)来调控宿主对内毒素的反应。
J Endotoxin Res. 2003;9(2):119-23. doi: 10.1179/096805103125001513.

引用本文的文献

1
An Epic Advancement in Targeting Macrophages for Cancer Therapy Approach.癌症治疗方法中靶向巨噬细胞的重大进展。
Curr Drug Deliv. 2024 Apr 8. doi: 10.2174/0115672018299798240403062508.
2
IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma.IL-33/ST2 信号及其与人类肝内胆管癌中巨噬细胞异质性和临床病理特征的相关性。
Curr Cancer Drug Targets. 2024;24(11):1144-1156. doi: 10.2174/0115680096276605240108112135.
3
Proinflammatory cytokines and colorectal cancer - the impact of the stage.
促炎细胞因子与结直肠癌——分期的影响
Contemp Oncol (Pozn). 2020;24(4):207-210. doi: 10.5114/wo.2020.102551. Epub 2021 Jan 4.
4
Absolute Neutrophil Count and Mean Platelet Volume in the Blood as Biomarkers to Detect Lung Cancer.血液中的绝对中性粒细胞计数和平均血小板体积可作为检测肺癌的生物标志物。
Dis Markers. 2020 Apr 21;2020:1371964. doi: 10.1155/2020/1371964. eCollection 2020.
5
Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer.巨噬细胞移动抑制因子(MIF)的基因变异体(-794 CATT5-8和-173 G>C)与乳腺癌女性中MIF和TNFα更高的可溶性水平的关联。
J Clin Lab Anal. 2020 May;34(5):e23209. doi: 10.1002/jcla.23209. Epub 2020 Jan 24.
6
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris.寻常疣患者巨噬细胞移动抑制因子的评估
Clin Cosmet Investig Dermatol. 2019 Aug 22;12:591-595. doi: 10.2147/CCID.S209269. eCollection 2019.
7
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.叙利亚金黄地鼠巨噬细胞移动抑制因子与人类同源物具有结构和功能上的相似性,并促进胰腺癌的发生。
Sci Rep. 2019 Oct 29;9(1):15507. doi: 10.1038/s41598-019-51947-7.
8
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.巨噬细胞移动抑制因子及功能相关基因D-DT、CD74、CD44、CXCR2和CXCR4在胶质母细胞瘤中的过表达
Oncol Lett. 2018 Sep;16(3):2881-2886. doi: 10.3892/ol.2018.8990. Epub 2018 Jun 19.
9
Diabetes-associated dysregulated cytokines and cancer.糖尿病相关的细胞因子失调与癌症
Integr Cancer Sci Ther. 2016 Feb;3(1):370-378. doi: 10.15761/ICST.1000173. Epub 2016 Feb 15.
10
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells.CD74在膀胱癌中的表达及其与HT - 1376细胞中癌症增殖、侵袭和血管生成相关的抑制作用。
Oncol Lett. 2018 May;15(5):7631-7638. doi: 10.3892/ol.2018.8309. Epub 2018 Mar 21.